Ginkgo Bioworks Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
Ginkgo Bioworks Holdings, Inc. filed a Form 8-K concerning a change in its accounting leadership. The earliest reported event occurred on May 1, 2023; the filing was dated May 5, 2023. No quarterly or annual financial results are reported.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating performance metrics.
Material Changes Versus the Prior Comparable Period
- Marie E. Fallon notified the Company on May 1, 2023 that she would resign as Chief Accounting Officer effective May 15, 2023.
- Ms. Fallon agreed to remain an employee through June 2, 2023 and then serve as a consultant for an interim period.
- Subject to Board approval, Steven P. Coen was appointed Chief Accounting Officer effective May 15, 2023. He joined the Company on May 1, 2023.
Compensation, Outlook, Risks, and Unusual Items
- Mr. Coen will receive an annual base salary of $400,000.
- Subject to Board approval, he will receive a restricted stock unit grant valued at $1.5 million, calculated using the average closing price of the Class A common stock over the 30 consecutive trading days ending June 1, 2023. The award will vest over four years with a one-year cliff.
- Mr. Coen will be eligible for the Company’s deferred compensation plan and other applicable benefits.
- The filing states that Ms. Fallon’s resignation was not due to disagreement with the Company regarding its financial statements, operations, policies, or practices.
- Mr. Coen has more than 30 years of public accounting and corporate finance experience, most recently serving as Corporate Vice President and Corporate Controller at Charles River Laboratories.
Important Facts for Investors to Verify
- Confirm the Board’s approval of Mr. Coen’s appointment and equity grant.
- Verify the final number and vesting terms of the restricted stock units after the applicable share-price calculation.
- Monitor the transition from Ms. Fallon’s employee role to her interim consulting arrangement.
- Review Exhibit 99.1, the Company’s May 5, 2023 press release, for additional announcement details.